Astellas Innovation Management (AIM) sounds like a partnership program that would target a company with a product like AAGP. AAGP has been proven “remarkably safe” in human clinical trials and those trials have seen a possible benefit regarding TAC. I think we have a winner!
Market Data 
Markets 
AI
